Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $638.8600 (-2.9%) ($635.6420 - $658.0000) on Tue. Jul. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.57% (three month average) | RSI | 56 | Latest Price | $638.8600(-2.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(40%) IVW(38%) IWF(37%) | Factors Impacting REGN price | REGN will decline at least -1.285% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) IYT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.285% (StdDev 2.57%) | Hourly BBV | -1.4 () | Intraday Trend | -2.9% | | | |
|
5 Day Moving Average | $641.21(-0.37%) | 10 Day Moving Average | $636.49(0.37%) | 20 Day Moving Average | $628.53(1.64%) | To recent high | -2.9% | To recent low | 23.9% | Market Cap | $67.737b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |